| 000 | 01709 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250516201839.0 | ||
| 264 | 0 | _c20150723 | |
| 008 | 201507s 0 0 eng d | ||
| 022 | _a1873-2518 | ||
| 024 | 7 |
_a10.1016/j.vaccine.2014.02.052 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLeroux-Roels, Geert | |
| 245 | 0 | 0 |
_aSafety, reactogenicity and immunogenicity of a novel pneumococcal protein-based vaccine in adults: a phase I/II randomized clinical study. _h[electronic resource] |
| 260 |
_bVaccine _cNov 2014 |
||
| 300 |
_a6838-46 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAntibodies, Bacterial _xblood |
| 650 | 0 | 4 |
_aBacterial Proteins _ximmunology |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 |
_aDrug-Related Side Effects and Adverse Reactions _xepidemiology |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHealthy Volunteers |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHydrolases _ximmunology |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aPlacebos _xadministration & dosage |
| 650 | 0 | 4 |
_aPneumococcal Vaccines _xadministration & dosage |
| 650 | 0 | 4 |
_aStreptococcus pneumoniae _ximmunology |
| 650 | 0 | 4 |
_aStreptolysins _ximmunology |
| 650 | 0 | 4 |
_aVaccination _xadverse effects |
| 650 | 0 | 4 | _aYoung Adult |
| 700 | 1 | _aMaes, Cathy | |
| 700 | 1 | _aDe Boever, Fien | |
| 700 | 1 | _aTraskine, Magali | |
| 700 | 1 | _aRüggeberg, Jens U | |
| 700 | 1 | _aBorys, Dorota | |
| 773 | 0 |
_tVaccine _gvol. 32 _gno. 50 _gp. 6838-46 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.vaccine.2014.02.052 _zAvailable from publisher's website |
| 999 |
_c23620392 _d23620392 |
||